Applied Biosystems & Bio-Rad Gain Gene Expression Profiling Market
Share
Dynamic Gene Expression Profiling Market Revealed in Percepta
Associates New Gene Expression Profiling Life Science DashboardTM Market
Research Report
CARLSBAD, Calif. (Business Wire EON/PRWEB ) May 5, 2008 --
Today Percepta Associates
Inc. announced the release of Series Two of its Gene
Expression Profiling Life Science DashboardTM market research
report. Drawing comparisons to the findings of Series One published in
February 2007, Percepta reports measurable shifts in market share within
this market.
Percepta’s survey of active global life
science researchers revealed that Applied Biosystems (NYSE:ABI)
and Bio-Rad Laboratories (AMEX:BIO) have enjoyed the
greatest gains in overall market share in the largest expression
profiling segments. Affymetrix (NASDAQ:AFFX) remains the
strong leader in its primary market segment, microarray-based expression
profiling, but other companies appear to be making headway. This new Gene
Expression Profiling DashboardTM reveals Invitrogen (NASDAQ:IVGN),
Agilent Technologies (NYSE:A), and Roche Applied
Sciences (VTX:ROG.VX) are among other companies that
experienced market share changes in 2007. Contributing to these market
dynamics is an increase in nearly all segments in researcher’s
desire to switch gene expression product suppliers for a variety of
performance or service reasons.
Product segments analyzed in Series Two of the new Gene
Expression Profiling Life Science DashboardTM include:
• Microarray-based gene expression
analysis
• Serial analysis of gene
expression (SAGE)
• Differential gene expression
analysis using multiplex PCR
• qRT-PCR analysis using gene
specific probes
• qRT-PCR analysis using SYBR Green
• Northern Blot analysis
• Transcriptome studies using
tiling arrays (new in Series Two)
• Transcriptome studies using short
read sequencing (new in Series Two)
Gene expression profiling methods enable the detection and measurement
of multiple expressed gene transcripts in a single RNA sample.
Continually evolving methods, such as microarray analysis, multiplex PCR
and quantitative real-time PCR, are integral to deciphering the
molecular mechanisms involved in gene function, biological development
and disease progression, and are important tools in the discovery and
development of new drug targets and diagnostic biomarkers.
“The expression profiling market
churn observed in this market research report illustrates how the
genomics market will be changing as new technologies are embraced that
enable researchers to integrate genetic analysis methods more cost
effectively and extract even more information from a single sample.”
said Scott
Provost, Principal at Percepta. “The most
successful life science market suppliers will monitor the early market
indicators, anticipate change and rapidly make the strategic adjustments
needed to secure market leadership. The Life
Science DashboardTM series was designed to support this process.”
To view gene expression profiling market research sample data and
questionnaires visit:
http://www.perceptaassociates.com/publications/08_gene_expression_
overview.shtml (Due to its length, this URL may need to be
copied/pasted into your Internet browser's address field. Remove the
extra space if one exists.)
Life Science Dashboards™ are readily
accessible sources of current, segment-specific, market research.
Designed and implemented by industry veterans, each dashboard provides
key life science market indicators compiled from the survey responses of
qualified decision-makers and researchers actively using life science
research products.
Unlike other market research reports, Percepta's Dashboards feature an “at-a-glance”
format that provides rapid access to actionable key market indicators in
an easy to understand framework, including:
• Market size
• Market share
• Market growth and reaction throughput rates
• Customer satisfaction
• Propensity to switch
• Competitive intensity
• Perceived pricing
• Top suppliers
• Technique usage frequency
• Fastest growing techniques
• Primary and secondary downstream
applications
About Percepta
Founded in 2005 in Carlsbad, California Percepta Associates serves a
rapidly growing roster of bioscience clients across North America and
Europe. Percepta is a specialized consultancy providing expert market
research, strategic business planning, portfolio management, product and
corporate branding and marketing communications services. For more
information visit www.perceptaassociates.com
Release Summary:
Today Percepta Associates Inc. announced the release of its Gene
Expression Profiling Life Science DashboardTM market research report.
Percepta reports measurable shifts in market share within this market.
KEYWORDS: Applied Biosystems, gene expression profiling, life
science, life science market research, market research
See the original story at: http://eon.businesswire.com/releases/market/expression/prweb916744.htm
Post Comment:
Trackback URL: http://www.prweb.com/pingpr.php/VGhpci1FbXB0LUZhbHUtUHJvZi1GYWx1LVplcm8=
Bookmark -
Del.icio.us |
Furl It |
Technorati |
Ask |
MyWeb |
Propeller |
Live Bookmarks |
Newsvine |
TailRank |
Reddit |
Slashdot |
Digg |
Stumbleupon |
Google Bookmarks |
Sphere |
Blink It |
Spurl
|
